Search

Your search keyword '"Klonowska, Katarzyna"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Klonowska, Katarzyna" Remove constraint Author: "Klonowska, Katarzyna"
38 results on '"Klonowska, Katarzyna"'

Search Results

1. Molecular EPISTOP, a comprehensive multi-omic analysis of blood from Tuberous Sclerosis Complex infants age birth to two years

3. TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study

5. Ultrasensitive profiling of UV-induced mutations identifies thousands of subclinical facial tumors in tuberous sclerosis complex

6. Cover Image

7. Comprehensive genetic and phenotype analysis of 95 individuals with mosaic tuberous sclerosis complex

8. Molecular EPISTOP, a comprehensive multi-omic analysis of blood from Tuberous Sclerosis Complex infants age birth to two years

9. Table S6 from Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations

10. Fig S1 from Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations

11. Suppl File from Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations

12. TSC2 inactivation, low mutation burden and high macrophage infiltration characterise hepatic angiomyolipomas.

13. Building knowledge capacity among patients and healthcare professionals to strengthen coordinated care in Poland using the experiences of the Scirocco Exchange project

14. Patients' health status following health check within POZ PLUS

18. Sporadic facial angiofibroma and sporadic angiomyolipoma mimicking tuberous sclerosis complex.

19. Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations

20. Performance of In Silico Prediction Tools for the Detection of Germline Copy Number Variations in Cancer Predisposition Genes in 4208 Female Index Patients with Familial Breast and Ovarian Cancer

21. Celecoxib in lymphangioleiomyomatosis: results of a phase I clinical trial

23. Primary Health Care PLUS project in Poland: disease management programs

24. BARD1 is a Low/Moderate Breast Cancer Risk Gene: Evidence Based on an Association Study of the Central European p.Q564X Recurrent Mutation

25. Meeting abstracts from the Annual Conference on Hereditary Cancers 2015

26. The 30 kb deletion in the APOBEC3 cluster decreases APOBEC3A and APOBEC3B expression and creates a transcriptionally active hybrid gene but does not associate with breast cancer in the European population

29. Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms

31. Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example

36. Oncogenomic portals for the visualization and analysis of genome-wide cancer data.

37. The modern methods of gastric imaging.

38. Dynamic CT of hepatic cirrhosis.

Catalog

Books, media, physical & digital resources